| 1 |
Deitch EA. Gut-origin sepsis: evolution of a concept[J]. Surgeon, 2012, 10(6): 350-356.
|
| 2 |
Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness[J]. Crit Care Clin, 2016, 32(2): 203-212.
|
| 3 |
Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer[J]. Lancet Gastroenterol Hepatol, 2025, 10(6): 573-592.
|
| 4 |
Pellegrini C, Fornai M, D'Antongiovanni V, et al. The intestinal barrier in disorders of the central nervous system[J]. Lancet Gastroenterol Hepatol, 2023, 8(1): 66-80.
|
| 5 |
Wang X, Peng J, Cai P, et al. The emerging role of the gut microbiota and its application in inflammatory bowel disease[J]. Biomed Pharmacother, 2024, 179: 117302.
|
| 6 |
Cho NA, Strayer K, Dobson B, et al. Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness[J]. Gut Microbes, 2024, 16(1): 2351478.
|
| 7 |
Battaglini D, Torres A. Gut microbiota and its impact on critical illness[J]. Curr Opin Crit Care, 2025, 31(2): 189-197.
|
| 8 |
White Z, Cabrera I, Mei L, et al. Gut inflammation promotes microbiota-specific CD4 T cell-mediated neuroinflammation[J]. Nature, 2025, 643(8071): 509-518.
|
| 9 |
Patel JJ, Barash M. The gut in critical illness[J]. Curr Gastroenterol Rep, 2025, 27(1): 11.
|
| 10 |
中国抗癌协会肿瘤与微生态专业委员会, 湖北省免疫学会肿瘤与微生态专业委员会. 肠道微生态组学实验室标准化技术规范中国专家共识(2022版)[J]. 中华实验外科杂志, 2024, 41(8): 1873-1882.
|
| 11 |
Zhang D, Li Y, Ding L, et al. Prevalence and outcome of acute gastrointestinal injury in critically ill patients: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2018, 97(43): e12970.
|
| 12 |
Drakos P, Volteas P, Cleri NA, et al. Acute gastrointestinal injury and feeding intolerance as prognostic factors in critically ill COVID-19 patients[J]. J Gastrointest Surg, 2022, 26(1): 181-190.
|
| 13 |
Reintam Blaser A, Malbrain ML, Starkopf J, et al. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems[J]. Intensive Care Med, 2012, 38(3): 384-394.
|
| 14 |
Hu B, Sun R, Wu A, et al. Severity of acute gastrointestinal injury grade is a predictor of all-cause mortality in critically ill patients: a multicenter, prospective, observational study[J]. Crit Care, 2017, 21(1): 188.
|
| 15 |
亚洲急危重症协会中国腹腔重症协作组. 重症病人胃肠功能障碍肠内营养专家共识 (2021版)[J]. 中华消化外科杂志, 2021, 20(11): 1123-1136.
|
| 16 |
Reintam Blaser A, Padar M, Mändul M, et al. Development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients - A prospective multicenter observational study (iSOFA study)[J]. Clin Nutr, 2021, 40(8): 4932-4940.
|
| 17 |
McClave SA, Gualdoni J, Nagengast A, et al. Gastrointestinal dysfunction and feeding intolerance in critical illness: do we need an objective scoring system?[J]. Curr Gastroenterol Rep, 2020, 22(1): 1.
|
| 18 |
Lin J, Liu Y, Ke L, et al. Feeding intolerance score in critically ill patients with enteral nutrition: a post hoc analysis of a prospective study[J]. Nutr Clin Pract, 2022, 37(4): 869-877.
|
| 19 |
de Jong PR, González-Navajas JM, Jansen NJ. The digestive tract as the origin of systemic inflammation[J]. Crit Care, 2016, 20(1): 279.
|
| 20 |
Wang Y, Li Y, Zhang Y, et al. Development and validation of a nomogram for predicting 28-day mortality in critically ill patients with acute gastrointestinal injury: prospective observational study[J]. Front Nutr, 2024, 11: 1469870.
|
| 21 |
Shen C, Wang X, Xiao YY, et al. Comparing gastrointestinal dysfunction score and acute gastrointestinal injury grade for predicting short-term mortality in critically ill patients[J]. World J Gastroenterol, 2024, 30(42): 4523-4531.
|
| 22 |
Xu J, Shi W, Xie L, et al. Feeding intolerance in critically ill patients with enteral nutrition: a Meta-analysis and systematic review[J]. J Crit Care Med (Targu Mures), 2024, 10(1): 7-15.
|
| 23 |
Reintam Blaser A, Regli A, De Keulenaer B, et al. Incidence, risk factors, and outcomes of intra-abdominal hypertension in critically ill patients-a prospective multicenter study (IROI study)[J]. Crit Care Med, 2019, 47(4): 535-542.
|
| 24 |
Sikiric P, Seiwerth S, Skrtic A, et al. Acute compartment syndrome and intra-abdominal hypertension, decompression, current pharmacotherapy, and stable gastric pentadecapeptide BPC 157 solution[J]. Pharmaceuticals (Basel), 2025, 18(6): 866.
|
| 25 |
Sugrue M, Buhkari Y. Intra-abdominal pressure and abdominal compartment syndrome in acute general surgery[J]. World J Surg, 2009, 33(6): 1123-1127.
|
| 26 |
Soranno DE, Coopersmith CM, Brinkworth JF, et al. A review of gut failure as a cause and consequence of critical illness[J]. Crit Care, 2025, 29(1): 91.
|
| 27 |
Wu Y, Zhang Y, Yu Y, et al. Small intestinal γδ T17 cells promote SAE through STING/C1q-induced microglial synaptic pruning in male mice[J]. Nat Commun, 2025, 16(1): 6779.
|
| 28 |
Wu J, Ji K, Kang G, et al. Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis[J]. Pharmacol Res, 2025, 213: 107642.
|
| 29 |
Zhao J, Zhang Q, Cheng W, et al. Heart-gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion[J]. Cardiovasc Res, 2023, 119(6): 1390-1402.
|
| 30 |
Iwata Y, Nakade Y, Tokumaru T, et al. Gut-Kidney axis: novel insights in kidney diseases[J]. Chem Biodivers, 2025, 22(12): e01506.
|
| 31 |
Xie B, Wang M, Zhang X, et al. Gut-derived memory γδ T17 cells exacerbate sepsis-induced acute lung injury in mice[J]. Nat Commun, 2024, 15(1): 6737.
|
| 32 |
Kaur H, Kaur G, Ali SA. IL-33's role in the gut immune system: a comprehensive review of its crosstalk and regulation[J]. Life Sci, 2023, 327: 121868.
|
| 33 |
Hu JJ, Deng F, Sun QS, et al. Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate[J]. Gut Microbes, 2025, 17(1): 2486515.
|
| 34 |
Wang Y, Zhang Y, Liu Y, et al. Gut-liver axis: liver sinusoidal endothelial cells function as the hepatic barrier in colitis-induced liver injury[J]. Front Cell Dev Biol, 2021, 9: 702890.
|
| 35 |
Kang EJ, Cha MG, Kwon GH, et al. Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis[J]. Microbiome, 2024, 12(1): 181.
|
| 36 |
Cheng Y, Hu G, Deng L, et al. Therapeutic role of gut microbiota in lung injury-related cognitive impairment[J]. Front Nutr, 2024, 11: 1521214.
|
| 37 |
Guarino M, Di Ciaula A, Portincasa P, et al. Narrative review on microbiota and sepsis: the host's betrayal?[J]. Intern Emerg Med, 2026, 21(2): 607-619.
|
| 38 |
Lee ZY, Lew C, Ortiz-Reyes A, et al. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis[J]. Clin Nutr, 2023, 42(4): 519-531.
|
| 39 |
Dehghani MH, Saghafi F, Bordbari Z, et al. Investigating the effect of oral synbiotic on enteral feeding tolerance in critically ill patients: a double-blinded controlled clinical trial of gut microbiota[J]. Nutr Clin Pract, 2023, 38(2): 402-410.
|
| 40 |
Oliwa-Libumska K, Jaworska-Czerwinska A, Mallek-Grabowska M, et al. Fecal microbiota transplantation in a patient hospitalized in the intensive care unit - case report[J]. Heliyon, 2025, 11(4): e42793.
|
| 41 |
Xu Z, Wang T, Wang Y, et al. Short-chain fatty acids: key antiviral mediators of gut microbiota[J]. Front Immunol, 2025, 16: 1614879.
|
| 42 |
Hegelmaier T, Duscha A, Desel C, et al. Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study[J]. Sci Rep, 2025, 16(1): 315.
|
| 43 |
黄曼, 丁朔. 脓毒症的诊治现状及挑战[J]. 诊断学理论与实践, 2025, 24(6): 583-592.
|
| 44 |
Martin ND, Schott LL, Miranowski MK, et al. Exploring the impact of arginine-supplemented immunonutrition on length of stay in the intensive care unit: a retrospective cross-sectional analysis[J]. PLoS One, 2024, 19(4): e0302074.
|
| 45 |
Koch JL, Lew C, Kork F, et al. The efficacy of fiber-supplemented enteral nutrition in critically ill patients: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis[J]. Crit Care, 2024, 28(1): 359.
|
| 46 |
Ramaswamy T, DeWane MP, Dashti HS, et al. Nine myths about enteral feeding in critically ill adults: an expert perspective[J]. Adv Nutr, 2025, 16(1): 100345.
|
| 47 |
Michailidou EM. Management of gastrointestinal failure in the adult critical care environment[J/OL]. Journal of Gastroenterology & Hepatology Reports, 2025, 6(5): 1-6.
|
| 48 |
Kokai-Kun JF, Roberts T, Coughlin O, et al. Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial[J]. Lancet Infect Dis, 2019, 19(5): 487-496.
|
| 49 |
Messaoudene M, Ferreira S, Saint-Lu N, et al. The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase Ⅰ trial in healthy volunteers[J]. Nat Commun, 2024, 15(1): 8083.
|
| 50 |
Cusumano G, Flores GA, Venanzoni R, et al. The impact of antibiotic therapy on intestinal microbiota: dysbiosis, antibiotic resistance, and restoration strategies[J]. Antibiotics (Basel), 2025, 14(4): 371.
|